A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Revolution Medicines, Inc.
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
DxTerity Diagnostics
Genmab
Kineta Inc.
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Exact Sciences Corporation
SpeciCare
ImmunoFrontier, Inc.
Astellas Pharma Inc